Cytopenia

21 registered clinical trials studyying Cytopenia — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Suspended	177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cyt NCT07025512	M.D. Anderson Cancer Center	Phase 2
Recruiting	Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in Cytopenia Patients NCT07081087	Weizmann Institute of Science	—
Recruiting	Feasibility and Safety of Exercise in Patients With Low-risk Myeloid Cancers and Precursor Conditions NCT06773871	Rigshospitalet, Denmark	N/A
Recruiting	Early Intervention in High Risk CCUS NCT06802146	Lachelle D. Weeks, MD, PhD	EARLY_Phase 1
Recruiting	Danazol for Treatment of Cytopenias in Patients With Cirrhosis NCT04873102	University of Southern California	Phase 2
Recruiting	A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia NCT06285825	M.D. Anderson Cancer Center	Phase 2
Recruiting	A Study of Emapalumab for Pediatric Aplastic Anemia NCT06430788	Memorial Sloan Kettering Cancer Center	Phase 2
Active Not Recruiting	Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion NCT05236764	Baylor College of Medicine	N/A
Recruiting	Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS NCT04741945	Kirsten Grønbæk	Phase 2
Recruiting	A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Synd NCT04419649	Takeda	Phase 2
Unknown	Autoimmune Cytopenias as a Sign of Primary Immunodeficiency. NCT06276036	Meyer Children's Hospital IRCCS	N/A
Active Not Recruiting	Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malign NCT03682029	Rigshospitalet, Denmark	N/A
Unknown	Improving Diagnosis in Idiopathic Cytopenia Using Gene Sequencing NCT03026751	Royal Marsden NHS Foundation Trust	—
Recruiting	Pre-myeloid Cancer and Bone Marrow Failure Clinic Study NCT02958462	Mayo Clinic	N/A
Terminated	Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study NCT03733249	Bellicum Pharmaceuticals	Phase 1 / Phase 2
Terminated	Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant NCT02065869	Bellicum Pharmaceuticals	Phase 1 / Phase 2
Active Not Recruiting	Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant NCT03301168	Bellicum Pharmaceuticals	Phase 1 / Phase 2
Completed	Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogenei NCT02104440	Red de Terapia Celular	Phase 2
Completed	Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decit NCT01928537	Traws Pharma, Inc.	Phase 3
Completed	National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia. NCT04070612	University Hospital, Bordeaux	—
Completed	Low Bacterial Diet in Patients With Cytopenia NCT00367588	Maastricht University Medical Center	N/A